Wolff Wiese Magana LLC Spring Works Therapeutics, Inc. Transaction History
Wolff Wiese Magana LLC
- $146 Million
- Q4 2024
A detailed history of Wolff Wiese Magana LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 168 shares of SWTX stock, worth $9,959. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168
Previous 168
-0.0%
Holding current value
$9,959
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
242Shares Held
70.7MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA7.16MShares$424 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$333 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$228 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$208 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$203 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.7B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...